Evaluating the Safety and Immunogenicity of an HIV-1 gp41 MPER-656 Liposome Vaccine in Healthy, HIV-uninfected Adult Participants

计划入组 24 人 · 首次发布于 2019 年 5 月 2 日

The Effect of Olive Leaf Extract on Upper Respiratory Illness in High School Athletes

计划入组 50 人

A trial of a herbal preparation (Link Samahan R) on the incidence of upper respiratory symptoms

MPER-656 liposome vaccine

MPER-656 liposome subunit vaccine (NIAID)

MPER-656 liposome vaccine(National Institute of Allergy & Infectious Diseases)

Mpex Pharmaceuticals, Inc.

United States

Per Humpert

Germany

Carlsson, Per-Ola

Sweden

HIV Vaccine Breakthrough: New Candidate Successfully Generates Broadly Neutralizing Antibodies

Meijer Expands Vaccine Access with New Schedule-Ahead Feature and Mobile Clinics Ahead of Flu Season

Ensysce Biosciences' PF614-MPAR Demonstrates Overdose Protection in Clinical Trial